Diabetes Updates

‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 billion in direct healthcare costs each year. Researchers from the Baker Heart and Diabetes Institute, Melbourne say Australia’s cholesterol problem remains unsolved as cardiovascular disease